LRGHealthcare in collaboration with NH Oncology/Hematology is one of only six community oncology practices in the country recognized by the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) for their work in improving cancer care through high-quality clinical trials programs. The 2012 Conquer Cancer Foundation of ASCO Clinical Trials Participation Award will be presented to Dr Charles Catcher on behalf of LRGHealthcare’s Oncology Department at ASCO’s 48th Annual Meeting in Chicago, taking place June 1-5, 2012.
“Our number one goal is to provide patients with high quality, comprehensive cancer care. The success of our research program is in large part due to the tremendous efforts of Dr Charles Catcher and Dr Robert Friedlander of NH Oncology/Hematology. It is their dedication to bring quality cancer research to a small community setting that really sets us apart,” said Clinical Trials Coordinator Dawn Coleman, RN, BSN, OCN.
“Our administrative support as well as full cooperation from multiple departments also contributes to the overall success of our program. The oncology nurses, pharmacist, and support staff are simply amazing and an absolute necessity in implementing this type of program. It is also important to acknowledge our courageous patients, who enroll in clinical trials with no guarantee for themselves, but are committed to helping to improve the treatment and outcome for all future cancer patients.”
Of the 1.3 million people who will be diagnosed with cancer this year, only 3 to 5 percent will participate in cancer clinical trials. Since the program started in 2003, LRGHealthcare has enrolled 300 patients in clinical trials, giving them the opportunity to receive cutting-edge cancer therapies. LRGHealthcare currently has 17 - 20 ongoing clinical trials for multiple different cancer types, including Lung, Breast, Colon, Lymphoma, Prostate, Bladder, Kidney, and Leukemia.
“The Conquer Cancer Foundation and ASCO are pleased to honor LRGHealthcare with the Clinical Trials Participation Award for providing patients with access to high-quality clinical research that contributes towards progress against cancer,” said Martin J. Murphy, Jr., PhD, DMedSc, chair of the Conquer Cancer Foundation Board of Directors.
Clinical trials are research studies designed to evaluate whether a new treatment or procedure is better than the current standard of care. Thanks in large part to the knowledge gained through clinical trials, today two-thirds of cancer patients survive at least five years after diagnosis, compared with half only in the 1970s.
This year’s award winners were selected based on several factors, including patient accrual to clinical trials. Special consideration was given to practices that increased clinical trial participation among underrepresented populations, as well as practices that use innovative techniques to overcome barriers to the enrollment of cancer patients in clinical trials. LRGHealthcare and NH Oncology/Hematology are very proud of the recognition this awards gives to cancer research in small community settings.
The Clinical Trials Participation Awards program has been supported by the Coalition of Cancer Cooperative Groups for 10 consecutive years which enables the Conquer Cancer Foundation to provide award recipients with a travel grant and complimentary registration to attend this year’s ASCO Annual Meeting.
For more information on participating in a clinical trial at LRGHealthcare, contact the Oncology Department at (603) 527-2905 or visit www.lrgh.org.
LRGHealthcare is a not-for-profit healthcare charitable trust representing Lakes Region General Hospital, Franklin Regional Hospital, and affiliated medical providers. LRGHealthcare’s mission is to provide quality, compassionate care and to strengthen the well-being of our community.
About the Conquer Cancer Foundation
The Conquer Cancer Foundation is working to create a world free from the fear of cancer by funding breakthrough research, by sharing knowledge with physicians and patients worldwide, and by supporting initiatives to ensure that all people have access to high-quality cancer care. Working in close collaboration with a global network of top scientists and clinicians, as well as leading advocacy and research organizations, the Foundation draws on the passion and expertise of the more than 30,000 oncology professionals who are members of its affiliate organization, the American Society of Clinical Oncology (ASCO). For more information, visit www.conquercancerfoundation.org.
About the American Society of Clinical Oncology
The American Society of Clinical Oncology (ASCO) is the world’s leading professional organization representing physicians who care for people with cancer. With more than 30,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation, which funds ground-breaking research and programs that make a tangible difference in the lives of people with cancer. For ASCO information and resources, visit www.asco.org. Patient-oriented cancer information is available at www.cancer.net.
Pictured left to right: LRGHealthcare and NHOH Oncology and Research Team, Clinical Trial Coordinator Dawn Coleman, RN, BSN, OCN, Dr. Charles Catcher, Dr. Robert Friedlander, Clinical Trial Data Manager Susan McGarry, Clinical Oncology Pharmacist Douglas Doyle, RPH and Oncology Director Marge Kerns are proud to be one of only six community oncology practices in the country recognized by the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) for their work in improving cancer care through high-quality clinical trials programs.
FOR MORE INFORMATION CONTACT:
Office of Public Relations & Marketing
80 Highland Street
Laconia, NH 03246
Phone (603) 737-1041
Fax (603) 737-1027